1. Home
  2. PHGE vs JDZG Comparison

PHGE vs JDZG Comparison

Compare PHGE & JDZG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHGE
  • JDZG
  • Stock Information
  • Founded
  • PHGE 2015
  • JDZG 2020
  • Country
  • PHGE Israel
  • JDZG China
  • Employees
  • PHGE N/A
  • JDZG N/A
  • Industry
  • PHGE Biotechnology: Pharmaceutical Preparations
  • JDZG Other Consumer Services
  • Sector
  • PHGE Health Care
  • JDZG Real Estate
  • Exchange
  • PHGE Nasdaq
  • JDZG Nasdaq
  • Market Cap
  • PHGE 26.5M
  • JDZG 29.3M
  • IPO Year
  • PHGE N/A
  • JDZG 2024
  • Fundamental
  • Price
  • PHGE $0.49
  • JDZG $0.69
  • Analyst Decision
  • PHGE Strong Buy
  • JDZG
  • Analyst Count
  • PHGE 2
  • JDZG 0
  • Target Price
  • PHGE $22.50
  • JDZG N/A
  • AVG Volume (30 Days)
  • PHGE 159.9K
  • JDZG 341.4K
  • Earning Date
  • PHGE 11-14-2024
  • JDZG 11-26-2024
  • Dividend Yield
  • PHGE N/A
  • JDZG N/A
  • EPS Growth
  • PHGE N/A
  • JDZG N/A
  • EPS
  • PHGE N/A
  • JDZG 0.06
  • Revenue
  • PHGE N/A
  • JDZG $2,195,958.00
  • Revenue This Year
  • PHGE N/A
  • JDZG N/A
  • Revenue Next Year
  • PHGE N/A
  • JDZG N/A
  • P/E Ratio
  • PHGE N/A
  • JDZG $11.95
  • Revenue Growth
  • PHGE N/A
  • JDZG 52.08
  • 52 Week Low
  • PHGE $0.49
  • JDZG $0.45
  • 52 Week High
  • PHGE $8.55
  • JDZG $15.08
  • Technical
  • Relative Strength Index (RSI)
  • PHGE 21.78
  • JDZG N/A
  • Support Level
  • PHGE $0.56
  • JDZG N/A
  • Resistance Level
  • PHGE $0.79
  • JDZG N/A
  • Average True Range (ATR)
  • PHGE 0.10
  • JDZG 0.00
  • MACD
  • PHGE -0.02
  • JDZG 0.00
  • Stochastic Oscillator
  • PHGE 0.00
  • JDZG 0.00

About PHGE BiomX Inc. COmmon Stock

BiomX Inc is a clinical-stage microbiome company based in Israel. The company is engaged in developing both natural and engineered phage cocktails designed to target and destroy harmful bacteria that affect the appearance of the skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease, colorectal cancer, and primary sclerosing cholangitis. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF.

About JDZG JIADE LIMITED Common stock

Jiade Ltd Ltd is engaged in providing one-stop comprehensive education supporting services to adult education institutions, through a wide range of software platforms and auxiliary solutions. The Group offers pre-enrollment guidance on school/selection and application development, training for entrance exams, and assistance in the application process. The Group also offers offline tutoring, exam administration services, guidance on graduation thesis, and social practice assistance in the People's Republic of China.

Share on Social Networks: